undamentalytics Newsletter

Neogen vs Varex Imaging

Neogen and Varex Imaging are similar in size: $870m and $845m of revenue in their latest fiscal years. Varex Imaging grew faster (4.1% against -2.7%). Neogen kept more of each dollar of sales as profit: a net margin of -0.9% against -8.3%. Neogen carries less debt relative to equity (38.2% against 78.3%).

Latest fiscal yearNeogenNEOG, 2026Varex ImagingVREX, 2025
Revenue $870m $845m
Revenue growth -2.7% 4.1%
Net income −$7.9m −$70.3m
Operating margin -2.5% -3.3%
Net margin -0.9% -8.3%
Return on equity -0.4% -14.0%
Free cash flow $31.9m $18.8m
Cash $186m $145m
Total debt $800m $370m
Debt to equity 38.2% 78.3%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 2,636 2,400
Market value $2.64bn $781m
Price vs our value range — Above our value range
Moat score 44 (Weak) 52 (Moderate)
Insider trades, 12 months 7 buys, 0 sales 0 buys, 3 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.